Intestinal effect of morphine 6-glucuronide: in vivo and in vitro characterization

Eur J Pharmacol. 1994 Mar 3;253(3):269-74. doi: 10.1016/0014-2999(94)90201-1.

Abstract

Morphine 6-glucuronide, a major metabolite of morphine with potent analgesic actions, is a potent inhibitor of intestinal motility when administered to rats by the intracerebroventricular (i.c.v.) route. Morphine 6-glucuronide was 62-fold more active than morphine in inhibiting gastrointestinal transit, whereas it was only 25-fold more potent in abolishing intestinal migrating myoelectric complexes. Pretreatment with naloxone (5 micrograms/rat i.c.v.) completely prevented the disappearance of migrating myoelectric complexes induced by the morphine metabolite. In contrast, in the guinea pig ileum bioassay, morphine 6-glucuronide and morphine inhibited the electrically evoked contractions of the tissue with similar potency, although in the guinea pig ileum binding assay the metabolite showed 4-fold lower affinity for the opiate receptor. The low naloxone Ke values against morphine 6-glucuronide or morphine indicated that the action of both drugs in guinea pig ileum was mediated by mu-opioid receptors.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Binding Sites
  • Drug Interactions
  • Gastrointestinal Motility / drug effects*
  • Gastrointestinal Transit / drug effects*
  • Guinea Pigs
  • Ileum / drug effects
  • Ileum / physiology
  • In Vitro Techniques
  • Injections, Intraventricular
  • Male
  • Morphine Derivatives / administration & dosage
  • Morphine Derivatives / metabolism
  • Morphine Derivatives / pharmacology*
  • Muscle Contraction / drug effects
  • Muscle, Smooth / drug effects
  • Myenteric Plexus / drug effects
  • Naloxone / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Opioid, mu / metabolism

Substances

  • Morphine Derivatives
  • Receptors, Opioid, mu
  • Naloxone
  • morphine-6-glucuronide